Clinical and Experimental Study on Angiopoietin-like Protein 8 Associated with Proliferative Diabetic Retinopathy

Overview

Journal Int J Ophthalmol

Specialty Ophthalmology

Date 2017 Dec 21

PMID 29259898

Authors

Chang-Xia Dong

Cai-Ping Song

Chun-Ping Zhang

Mei Dong

Xiu-Rong Gong

He-Ying Gao

Hong Wang

Affiliations

Soon will be listed here.

Abstract

Aim: To confirm the role of angiopoietin-like protein 8 (Angptl 8) in proliferative diabetic retinopathy (PDR).

Methods: The sera and aqueous humor of 10 PDR patients and 10 non-diabetic retinopathy (NDR) patients (idiopathic macular hole patients) were collected and the expression of Angptl 8 was detected by enzyme linked immune-sorbent assay (ELISA). Experimental diabetes mice model was induced with streptozotocin. The expression of glycosylated hemoglobin and Angptl 8 in sera was detected. Recombinant Angptl 8 was re-infused into wild type (WT) diabetic mice and spatial frequency threshold and contrast sensitivity were measured. retinal pigment epithelium (RPE) were stimulated by recombinant Angptl 8 for 24h. MMT assay were used to detect cell proliferation. At the same time, qRT-PCR and Western blot was used to measure the expression of proliferation-related factors in PRE cells.

Results: The expression of Angptl 8 was markedly increased in the sera and aqueous humor of PDR patients (=99.02, <0.0001 in sera; =10.42, <0.0001 in aqueous). After successfully establishing the diabetic mice model, we found that glycosylated hemoglobin and Angptl 8 expression levels were increased. Re-infusion of recombinant Angptl 8 into WT diabetic mice could further decrease spatial frequency threshold and contrast sensitivity (<0.01). , RPE cells stimulated by recombinant Angptl 8 could increase the relative absorbance of MMT assay (1.486±0.042 1.000±0.104, <0.05) and proliferating cell nuclear antigen (PCNA) expression (0.55±0.01 0.29±0.03, <0.05). The proliferative effect of Angptl 8 is mainly mediated by increasing the expression of proliferation-activating factors cyclin A1 (4.973±0.205 2.720±0.197, <0.05), cyclin F (5.690±0.219 4.297±0.292, <0.05) and E2F2 (2.297±0.102 1.750±0.146, <0.05), and reducing the expression of proliferation-inhibiting factors cdkn1 (2.370±0.074 3.317±0.135, <0.05) and cdkn2 (4.793±0.065 5.387±0.149, <0.05).

Conclusion: The expression of Angptl 8 is increased in PDR, and the increased Angptl 8 can promote proliferation and increase proliferation-related factors.

References

Wang Y, Quagliarini F, Gusarova V, Gromada J, Valenzuela D, Cohen J . Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis. Proc Natl Acad Sci U S A. 2013; 110(40):16109-14. PMC: 3791734. DOI: 10.1073/pnas.1315292110. View

Lee R, Wong T, Sabanayagam C . Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2015; 2:17. PMC: 4657234. DOI: 10.1186/s40662-015-0026-2. View

Vikram A, Jena G . S961, an insulin receptor antagonist causes hyperinsulinemia, insulin-resistance and depletion of energy stores in rats. Biochem Biophys Res Commun. 2010; 398(2):260-5. DOI: 10.1016/j.bbrc.2010.06.070. View

Nakashima E, Pop-Busui R, Towns R, Thomas T, Hosaka Y, Nakamura J . Regulation of the human taurine transporter by oxidative stress in retinal pigment epithelial cells stably transformed to overexpress aldose reductase. Antioxid Redox Signal. 2005; 7(11-12):1530-42. DOI: 10.1089/ars.2005.7.1530. View

Lee C, Li G, Patel M, Petrash J, Benetz B, Veenstra A . Diabetes-induced impairment in visual function in mice: contributions of p38 MAPK, rage, leukocytes, and aldose reductase. Invest Ophthalmol Vis Sci. 2013; 55(5):2904-10. PMC: 4010365. DOI: 10.1167/iovs.13-11659. View

Ranjbar M, Brinkmann M, Tura A, Rudolf M, Miura Y, Grisanti S . Ranibizumab interacts with the VEGF-A/VEGFR-2 signaling pathway in human RPE cells at different levels. Cytokine. 2016; 83:210-216. DOI: 10.1016/j.cyto.2016.04.014. View

Yi P, Park J, Melton D . Betatrophin: a hormone that controls pancreatic β cell proliferation. Cell. 2013; 153(4):747-58. PMC: 3756510. DOI: 10.1016/j.cell.2013.04.008. View

Lu Q, Lu L, Chen W, Lu P . Expression of angiopoietin-like protein 8 correlates with VEGF in patients with proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2017; 255(8):1515-1523. DOI: 10.1007/s00417-017-3676-z. View

Suzuki Y, Suzuki K, Kudo T, Metoki T, Nakazawa M . Level of Vascular Endothelial Growth Factor in the Vitreous Fluid of Proliferative Diabetic Retinopathy Patients and Prognosis after Vitrectomy. Ophthalmologica. 2016; 236(3):133-138. DOI: 10.1159/000449261. View

10.

Bagheri A, Soheili Z, Ahmadieh H, Samiei S, Sheibani N, Astaneh S . Simultaneous application of bevacizumab and anti-CTGF antibody effectively suppresses proangiogenic and profibrotic factors in human RPE cells. Mol Vis. 2015; 21:378-90. PMC: 4392827. View

11.

Tseng Y, Yeh Y, Chen W, Lin K . Emerging regulation and function of betatrophin. Int J Mol Sci. 2014; 15(12):23640-57. PMC: 4284785. DOI: 10.3390/ijms151223640. View

12.

Rusnak S, Vrzalova J, Sobotova M, Hecova L, Ricarova R, Topolcan O . The Measurement of Intraocular Biomarkers in Various Stages of Proliferative Diabetic Retinopathy Using Multiplex xMAP Technology. J Ophthalmol. 2015; 2015:424783. PMC: 4600494. DOI: 10.1155/2015/424783. View

13.

Cheung N, Mitchell P, Wong T . Diabetic retinopathy. Lancet. 2010; 376(9735):124-36. DOI: 10.1016/S0140-6736(09)62124-3. View

14.

Saaddine J, Honeycutt A, Narayan K, Zhang X, Klein R, Boyle J . Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050. Arch Ophthalmol. 2008; 126(12):1740-7. DOI: 10.1001/archopht.126.12.1740. View

15.

Qaum T, Xu Q, Joussen A, Clemens M, Qin W, Miyamoto K . VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci. 2001; 42(10):2408-13. View

16.

Skottman H, Muranen J, Lahdekorpi H, Pajula E, Makela K, Koivusalo L . Contacting co-culture of human retinal microvascular endothelial cells alters barrier function of human embryonic stem cell derived retinal pigment epithelial cells. Exp Cell Res. 2017; 359(1):101-111. DOI: 10.1016/j.yexcr.2017.08.004. View

17.

Zhou W, Yu W, Xie W, Huang L, Xu Y, Li X . The role of SLIT-ROBO signaling in proliferative diabetic retinopathy and retinal pigment epithelial cells. Mol Vis. 2011; 17:1526-36. PMC: 3115746. View

18.

Funatsu H, Yamashita H, Noma H, Mimura T, Yamashita T, Hori S . Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema. Am J Ophthalmol. 2002; 133(1):70-7. DOI: 10.1016/s0002-9394(01)01269-7. View

19.

Shah A, Gardner T . Diabetic retinopathy: research to clinical practice. Clin Diabetes Endocrinol. 2017; 3:9. PMC: 5648499. DOI: 10.1186/s40842-017-0047-y. View

20.

Kocabora M, Telli M, Fazil K, Erdur S, Ozsutcu M, Cekic O . Serum and Aqueous Concentrations of Inflammatory Markers in Diabetic Macular Edema. Ocul Immunol Inflamm. 2015; 24(5):549-54. DOI: 10.3109/09273948.2015.1034804. View